The Roles of P-Glycoprotein and MRP1 in the Blood-Brain and Blood-Cerebrospinal Fluid Barriers
- 1 January 2001
- book chapter
- Published by Springer Nature
- Vol. 500, 365-372
- https://doi.org/10.1007/978-1-4615-0667-6_60
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrierJournal of Clinical Investigation, 2000
- Structural, mechanistic and clinical aspects of MRP1Biochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistanceBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposureJournal of Clinical Investigation, 1999
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- The physiological function of drug-transporting P-glycoproteinsSeminars in Cancer Biology, 1997
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987